IFFIm widely recognised for innovation

As the first development finance entity in history to attract long-term, irrevocable and legally binding commitments from donors, IFFIm has built a strong reputation for innovation.

IFFIm's inaugural Uridashi bond included among the market's 25 most influential transactions by EuroWeek.

Cited as “SRI Innovation of the Decade” by mtn-i, the news / analytics provider.

IFFIm’s debut Sukuk was awarded Social Impact Deal of 2014 by Islamic Finance News.

Recognised for its role in investing in and aiding development by the Action Agenda of the Financing Development Conference in Addis Ababa, Ethiopia, in 2015. The Action Agenda, endorsed by representatives of the world’s governments, stated:
"...We encourage consideration of how existing mechanisms, such as the International Finance Facility for Immunisation, might be replicated to address broader development needs..."  

Financial Times/IFC

'Achievement in Transformational Finance Award' for IFFIm’s November 2014 sukuk.

US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

More facts...

close icon

modal window here